Home › Autism Spectrum Disorder › NCT06203938
Autism Research Project With Non-Invasive Near-Infrared Light Stimulation
Social and Behavioral Associations With Prefrontal Photobiomodulation in Autism Spectrum
Who can join
Ages 4 to 60 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age between 4-60 years Exclusion Criteria: * Current pregnancy
About the study
The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).
What is being tested
- Transcranial infrared light stimulation (device)
- Sham (device)
Sponsor: Francisco Gonzalez-Lima, PhD · Participants: 280 · Started: Jan 13, 2025
Contact the study team
- Francisco Gonzalez-Lima, PhD · Phone: 512-537-5257
Official record on ClinicalTrials.gov — NCT06203938
Locations in the U.S.
| Texas | Seay Psychology Building, Room 3.304, Austin |
Conditions
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.